Quantum Dot Cellular Uptake and Toxicity in the Developing Brain: Implications for Use as Imaging Probes.

Area of Science:

• Nanotechnology
• Neuroscience
• Biomedical Imaging

Background:

• Semiconductor quantum dots (QDs) offer advantages over traditional probes for in vivo imaging.
• Their application in central nervous system diseases is promising but lacks systematic evaluation in brain environments.

Purpose of the Study:

• To investigate quantum dot (QD) colloidal stability, cellular uptake, and toxicity in brain-relevant conditions.
• To compare QD behavior across in vitro, ex vivo, and in vivo models.
• To guide the engineering of QD-based neurological imaging probes.

Main Methods:

• Evaluated QD colloidal stability, cellular uptake, and toxicity in vitro, ex vivo (organotypic whole hemisphere slices), and in vivo.
• Assessed QD behavior with varying surface functionalities, including poly(ethylene glycol) (PEG) coating.
• Analyzed dose-dependent toxicity, metallothionein increase, and inflammatory cytokine/oxidative stress markers.

Main Results:

• QD behavior is critically dependent on surface functionality.
• PEG-coated QDs demonstrated improved colloidal stability and tissue penetration in neurophysiologically relevant fluids and tissue.
• QD behavior in cultured slices more closely mirrored in vivo observations than monolayer cultures.
• Non-aggregated QDs were primarily internalized by microglia in a region-dependent manner.

Conclusions:

• Surface functionalization is key to optimizing QD performance for neurological applications.
• Ex vivo organotypic whole hemisphere slice models provide a more relevant platform for predicting in vivo QD behavior than traditional cell cultures.
• Understanding QD-brain interactions, particularly microglial uptake, is essential for developing effective neuroimaging agents.